Insider Trading disclosures for Vaxart Inc

The latest disclosure was made by Sean N. Tucker in Vaxart Inc where a trade of 9,242 Common Stock done at an average price of $0.7 was reported to US exchanges on Feb. 2, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Sean N. Tucker	SVP, Chief Scientific Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share.	02 Feb 2025	9,242	346,453 (0%)	0%	0.7	6,283	Common Stock
James F. Cummings	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share.	02 Feb 2025	7,964	318,837 (0%)	0%	0.7	5,414	Common Stock
Edward B. Berg	SVP, General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share.	02 Feb 2025	9,242	261,464 (0%)	0%	0.7	6,283	Common Stock
Kevin Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2025	32,000	32,000 (0%)	0%		0	Common Stock
Kevin Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2025	190,800	190,800	-		-	Stock Option (right to buy)
Phillip E. Lee	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share.	15 Dec 2024	6,132	233,669 (0%)	0%	0.6	3,630	Common Stock
Phillip E. Lee	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share.	12 Jun 2024	2,007	239,801 (0%)	0%	0.8	1,525	Common Stock
Elaine J. Heron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	95,400	95,400	-		-	Stock Option (right to buy)
Elaine J. Heron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	16,000	40,566 (0%)	0%		0	Common Stock
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	95,400	95,400	-		-	Stock Option (right to buy)
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	16,000	686,840 (1%)	0%		0	Common Stock
David E. Wheadon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	16,000	30,750 (0%)	0%		0	Common Stock
David E. Wheadon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	95,400	95,400	-		-	Stock Option (right to buy)
Robert A. Yedid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	95,400	95,400	-		-	Stock Option (right to buy)
Robert A. Yedid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	16,000	34,490 (0%)	0%		0	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share.	28 Mar 2024	3,902	355,695 (0%)	0%	1.3	5,073	Common Stock
James F. Cummings	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share.	28 Mar 2024	3,292	326,801 (0%)	0%	1.3	4,280	Common Stock
Steven Lo	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Mar 2024	250,000	250,000 (0%)	0%		0	Common Stock
Steven Lo	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Mar 2024	1,000,000	1,000,000	-		-	Stock Option (right to buy)
James F. Cummings	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share.	08 Dec 2023	31,409	248,058 (0%)	0%	0.7	22,300	Common Stock
James F. Cummings	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	410,000	410,000	-		-	Stock Option (right to buy)
James F. Cummings	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	90,000	330,093 (0%)	0%		0	Common Stock
James F. Cummings	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share.	08 Dec 2023	7,965	240,093 (0%)	0%	1.2	9,558	Common Stock
Edward B. Berg	SVP, General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share.	08 Dec 2023	33,752	189,926 (0%)	0%	0.7	23,964	Common Stock
Edward B. Berg	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	410,000	410,000	-		-	Stock Option (right to buy)
Edward B. Berg	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	90,000	270,706 (0%)	0%		0	Common Stock
Edward B. Berg	SVP, General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share.	08 Dec 2023	9,220	180,706 (0%)	0%	1.2	11,064	Common Stock
Phillip E. Lee	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.63 per share.	08 Dec 2023	5,943	151,808 (0%)	0%	0.6	3,744	Common Stock
Phillip E. Lee	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	410,000	410,000	-		-	Stock Option (right to buy)
Phillip E. Lee	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	90,000	241,808 (0%)	0%		0	Common Stock
Phillip E. Lee	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share.	08 Dec 2023	35,151	157,751 (0%)	0%	0.7	24,957	Common Stock
Elaine J. Heron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jun 2023	6,922	24,566 (0%)	0%		0	Common Stock
Elaine J. Heron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jun 2023	41,510	41,510	-		-	Stock Option (right to buy)
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jun 2023	44,224	44,224	-		-	Stock Option (right to buy)
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jun 2023	7,375	670,840 (1%)	0%		0	Common Stock
David E. Wheadon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jun 2023	44,224	44,224	-		-	Stock Option (right to buy)
David E. Wheadon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jun 2023	7,375	14,750 (0%)	0%		0	Common Stock
Robert A. Yedid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jun 2023	7,375	18,490 (0%)	0%		0	Common Stock
Robert A. Yedid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jun 2023	44,224	44,224	-		-	Stock Option (right to buy)
Phillip E. Lee	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2023	102,500	102,500	-		-	Stock Option (right to buy)
Phillip E. Lee	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2023	22,500	192,902 (0%)	0%		0	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2023	410,000	410,000	-		-	Stock Option (right to buy)
Sean N. Tucker	SVP, Chief Scientific Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share.	28 Mar 2023	3,683	373,630 (0%)	0%	0.7	2,762	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share.	28 Mar 2023	34,288	339,342 (0%)	0%	0.7	24,344	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share.	28 Mar 2023	9,220	330,122 (0%)	0%	1.2	11,064	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2023	90,000	420,122 (0%)	0%		0	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	45,000	172,631 (0%)	0%		0	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	54,157	226,788 (0%)	0%		0	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	90,000	316,788 (0%)	0%		0	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	205,000	205,000	-		-	Stock Option (right to buy)
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	410,000	410,000	-		-	Stock Option (right to buy)
Andrei Floroiu	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	100,000	185,000 (0%)	0%		0	Common Stock
Andrei Floroiu	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	92,735	277,735 (0%)	0%		0	Common Stock
Andrei Floroiu	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	175,000	452,735 (0%)	0%		0	Common Stock
Andrei Floroiu	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	400,000	400,000	-		-	Stock Option (right to buy)
Andrei Floroiu	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	750,000	750,000	-		-	Stock Option (right to buy)
James F. Cummings	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	59,350	148,100 (0%)	0%		0	Common Stock
James F. Cummings	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	90,000	238,100 (0%)	0%		0	Common Stock
James F. Cummings	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	45,000	88,750 (0%)	0%		0	Common Stock
James F. Cummings	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	410,000	410,000	-		-	Stock Option (right to buy)
James F. Cummings	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	205,000	205,000	-		-	Stock Option (right to buy)
Edward B. Berg	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	205,000	205,000	-		-	Stock Option (right to buy)
Edward B. Berg	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	410,000	410,000	-		-	Stock Option (right to buy)
Edward B. Berg	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	90,000	187,606 (0%)	0%		0	Common Stock
Edward B. Berg	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	52,606	97,606 (0%)	0%		0	Common Stock
Edward B. Berg	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	45,000	45,000 (0%)	0%		0	Common Stock
Phillip E. Lee	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	205,000	205,000	-		-	Stock Option (right to buy)
Phillip E. Lee	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	56,652	170,402 (0%)	0%		0	Common Stock
Phillip E. Lee	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	45,000	113,750 (0%)	0%		0	Common Stock
Elaine J. Heron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Aug 2022	88,448	88,448	-		-	Stock Option (right to buy)
Elaine J. Heron	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Aug 2022	14,750	17,644 (0%)	0%		0	Common Stock
Robert A. Yedid	Director	Gift of securities by or to the insider at price $ 0.00 per share.	24 Aug 2022	4,000	11,115 (0%)	0%		-	Common Stock
Robert A. Yedid	Director	Gift of securities by or to the insider at price $ 0.00 per share.	24 Aug 2022	18,240	19,115 (0%)	0%		-	Common Stock
Robert A. Yedid	Director	Gift of securities by or to the insider at price $ 0.00 per share.	24 Aug 2022	4,000	15,115 (0%)	0%		-	Common Stock
Robert A. Yedid	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Aug 2022	8,000	57,700	-		-	Stock Option (right to buy)
Robert A. Yedid	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Aug 2022	18,240	18,240	-		-	Stock Option (right to buy)
Robert A. Yedid	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.31 per share.	19 Aug 2022	18,240	29,355 (0%)	0%	0.3	5,654	Common Stock
Robert A. Yedid	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share.	19 Aug 2022	8,000	37,355 (0%)	0%	2.4	19,120	Common Stock
Todd C. Davis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	44,224	44,224	-		-	Stock Option (right to buy)
Todd C. Davis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	7,375	125,905 (0%)	0%		0	Common Stock
Julie M. Cherrington	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	37,280	37,280	-		-	Stock Option (right to buy)
Julie M. Cherrington	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	6,217	6,217 (0%)	0%		0	Common Stock
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	7,375	663,465 (1%)	0%		0	Common Stock
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	44,224	44,224	-		-	Stock Option (right to buy)
David E. Wheadon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	7,375	7,375 (0%)	0%		0	Common Stock
David E. Wheadon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	44,224	44,224	-		-	Stock Option (right to buy)
Robert A. Yedid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	7,375	11,115 (0%)	0%		0	Common Stock
Robert A. Yedid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	44,224	44,224	-		-	Stock Option (right to buy)
Fuad Ahmad	Interim CFO	Purchase of securities on an exchange or from another person at price $ 3.22 per share.	22 Jun 2022	5,000	5,000 (0%)	0%	3.2	16,100	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Apr 2022	40,000	84,061	-		-	Stock Option (right to buy)
Sean N. Tucker	SVP, Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share.	22 Apr 2022	40,000	127,631 (0%)	0%	0.8	30,800	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2022	43,750	87,631 (0%)	0%		0	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2022	262,500	262,500	-		-	Stock Option (right to buy)
Andrei Floroiu	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2022	550,000	550,000	-		-	Stock Option (right to buy)
Andrei Floroiu	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2022	85,000	85,000 (0%)	0%		0	Common Stock
James F. Cummings	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2022	43,750	43,750 (0%)	0%		0	Common Stock
James F. Cummings	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2022	262,500	262,500	-		-	Stock Option (right to buy)
Edward B. Berg	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	285,000	285,000	-		-	Stock Option (right to buy)
Robert A. Yedid	Director	Sale of securities on an exchange or to another person at price $ 6.01 per share.	10 Jan 2022	1,500	0 (0%)	0%	6.0	9,015	Common Stock
Todd C. Davis	Director	Gift of securities by or to the insider at price $ 0.00 per share.	22 Dec 2021	1,470	118,530 (0%)	0%		0	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share.	30 Nov 2021	2,936	3,602 (0%)	0%	0.8	2,261	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share.	30 Nov 2021	666	666 (0%)	0%	5.2	3,443	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Nov 2021	2,936	26,416	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Nov 2021	666	1,667	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Sale of securities on an exchange or to another person at price $ 8.00 per share.	30 Nov 2021	3,602	0 (0%)	0%	8	28,816	Common Stock
Robert A. Yedid	Director	Gift of securities by or to the insider at price $ 0.00 per share.	12 Oct 2021	1,500	1,500 (0%)	0%		-	Common Stock
Robert A. Yedid	Director	Gift of securities by or to the insider at price $ 0.00 per share.	12 Oct 2021	1,500	3,740 (0%)	0%		-	Common Stock
Robert A. Yedid	Director	Gift of securities by or to the insider at price $ 0.00 per share.	12 Oct 2021	1,500	5,240 (0%)	0%		-	Common Stock
Robert A. Yedid	Director	Gift of securities by or to the insider at price $ 0.00 per share.	12 Oct 2021	1,500	6,740 (0%)	0%		-	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share.	10 Sep 2021	334	334 (0%)	0%	5.2	1,727	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Sep 2021	1,467	29,352	-		-	Stock Option (Right to Buy)
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Sep 2021	334	2,333	-		-	Stock Option (Right to Buy)
Margaret Echerd	SVP, Principal Accntng Officer	Sale of securities on an exchange or to another person at price $ 9.10 per share.	10 Sep 2021	1,801	0 (0%)	0%	9.1	16,389	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share.	10 Sep 2021	1,467	1,801 (0%)	0%	0.8	1,130	Common Stock
Julie M. Cherrington	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Aug 2021	65,700	65,700	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share.	10 Aug 2021	1,468	1,801 (0%)	0%	0.8	1,130	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Aug 2021	1,468	30,819	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Aug 2021	333	2,667	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Sale of securities on an exchange or to another person at price $ 10.00 per share.	10 Aug 2021	1,801	0 (0%)	0%	10	18,010	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share.	10 Aug 2021	333	333 (0%)	0%	5.2	1,722	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 10.20 per share.	10 Aug 2021	5,828	51,465 (0%)	0%	10.2	59,446	Common Stock
Sean N. Tucker	SVP, Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 10.20 per share.	10 Aug 2021	4,172	43,881 (0%)	0%	10.2	42,554	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Jul 2021	333	3,000	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share.	19 Jul 2021	333	333 (0%)	0%	5.2	1,722	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share.	19 Jul 2021	1,467	1,800 (0%)	0%	0.8	1,130	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Sale of securities on an exchange or to another person at price $ 8.00 per share.	19 Jul 2021	1,800	0 (0%)	0%	8	14,400	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Jul 2021	1,467	32,287	-		-	Stock Option (right to buy)
Michael J. Finney	Director		18 Jun 2021	181,818	0	-		-	Common Stock Purchase Warrant
Michael J. Finney	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share.	18 Jun 2021	9,000	461,572 (0%)	0%	0.7	6,120	Common Stock
Michael J. Finney	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share.	18 Jun 2021	12,700	474,272 (0%)	0%	0.7	8,636	Common Stock
Michael J. Finney	Director		18 Jun 2021	181,818	656,090 (1%)	0%	1.1	200,000	Common Stock
Michael J. Finney	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jun 2021	9,000	0	-		-	Stock Option (right to buy)
Michael J. Finney	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jun 2021	12,700	0	-		-	Stock Option (right to buy)
Todd C. Davis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,097	15,097	-		-	Stock Option (right to buy)
Karen J. Wilson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,097	15,097	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	100,000	100,000	-		-	Stock Option (right to buy)
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,097	15,097	-		-	Stock Option (right to buy)
Sean N. Tucker	SVP, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	100,000	100,000	-		-	Stock Option (right to buy)
David E. Wheadon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	65,700	65,700	-		-	Stock Option (right to buy)
Robert A. Yedid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	15,097	15,097	-		-	Stock Option (right to buy)
Andrei Floroiu	Director, President, Chief Exec Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2021	250,000	250,000	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share.	09 Jun 2021	35,222	47,555 (0%)	0%	0.8	27,121	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jun 2021	35,222	35,222	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jun 2021	12,333	3,667	-		-	Stock Option (right to buy)
Margaret Echerd	SVP, Principal Accntng Officer	Sale of securities on an exchange or to another person at price $ 8.00 per share.	09 Jun 2021	47,555	0 (0%)	0%	8	380,440	Common Stock
Margaret Echerd	SVP, Principal Accntng Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share.	09 Jun 2021	12,333	12,333 (0%)	0%	5.2	63,762	Common Stock
Wouter W. Latour	Director	Sale of securities on an exchange or to another person at price $ 6.54 per share.	06 May 2021	100,000	0 (0%)	0%	6.5	653,890	Common Stock
Wouter W. Latour	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 May 2021	100,000	700,000	-		-	Stock Option (right to buy)
Wouter W. Latour	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 May 2021	100,000	800,000	-		-	Stock Option (right to buy)
Wouter W. Latour	Director	Sale of securities on an exchange or to another person at price $ 7.13 per share.	06 May 2021	100,000	0 (0%)	0%	7.1	712,750	Common Stock
Wouter W. Latour	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share.	06 May 2021	100,000	100,000 (0%)	0%	1.7	170,000	Common Stock
Wouter W. Latour	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share.	06 May 2021	100,000	100,000 (0%)	0%	1.7	170,000	Common Stock
Sean N. Tucker	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Mar 2021	1,006	0	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.49 per share.	16 Mar 2021	1,006	48,053 (0%)	0%	6.5	6,529	Common Stock
Wouter W. Latour	Director	Sale of securities on an exchange or to another person at price $ 6.04 per share.	04 Mar 2021	150,000	0 (0%)	0%	6.0	906,450	Common Stock
Wouter W. Latour	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Mar 2021	150,000	213,261	-		-	Stock Option (right to buy)
Wouter W. Latour	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share.	04 Mar 2021	150,000	150,000 (0%)	0%	0.8	115,500	Common Stock
Wouter W. Latour	Director	Sale of securities on an exchange or to another person at price $ 6.32 per share.	23 Nov 2020	333,334	0 (0%)	0%	6.3	2,108,138	Common Stock
Karen J. Wilson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Aug 2020	65,700	65,700	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Aug 2020	4,026	0	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.49 per share.	13 Aug 2020	4,026	51,679 (0%)	0%	6.5	26,129	Common stock
Wouter W. Latour	Director		12 Aug 2020	166,667	333,334 (0%)	0%	0.3	50,000	Common stock
Wouter W. Latour	Director		12 Aug 2020	166,667	0	-		-	Common Stock Purchase Warrant
Andrei Floroiu	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2020	900,000	900,000	-		-	Stock Option (right to buy)
Andrei Floroiu	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2020	845,280	845,280	-		-	Stock Option (right to buy)
Todd C. Davis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2020	65,700	65,700	-		-	Stock Option (right to buy)
Margaret Echerd	VP, Corporate Controller, PAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2020	315,000	315,000	-		-	Stock Option (right to buy)
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2020	65,700	65,700	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2020	360,000	360,000	-		-	Stock Option (right to buy)
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2020	900,000	900,000	-		-	Stock Option (right to buy)
Robert A. Yedid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2020	65,700	65,700	-		-	Stock Option (right to buy)
Andrei Floroiu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2020	54,720	54,720	-		-	Stock Option (right to buy)
Todd C. Davis	Director	Sale of securities on an exchange or to another person at price $ 3.28 per share.	28 Apr 2020	60,000	120,000 (0%)	0%	3.3	196,500	Common stock
Todd C. Davis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Nov 2019	54,720	54,720	-		-	Stock Option (right to buy)
Robert A. Yedid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Nov 2019	54,720	54,720	-		-	Stock Option (right to buy)
John P. Richard	Director	Purchase of securities on an exchange or from another person at price $ 0.38 per share.	11 Oct 2019	20,000	20,000 (0%)	0%	0.4	7,680	Common stock
Wouter W. Latour	Director, President and Chief Executive	Purchase of securities on an exchange or from another person at price $ 0.30 per share.	30 Sep 2019	166,667	166,667 (0%)	0%	0.3	50,000	Common stock
Wouter W. Latour	Director, President and Chief Executive	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	30 Sep 2019	166,667	166,667	-		-	Common Stock Purchase Warrant
Anne M. Vanlent	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	12,700	12,700	-		-	Stock Option (right to buy)
Anne M. Vanlent	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	9,000	9,000	-		-	Stock Option (right to buy)
Geoffrey F. Cox	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	9,000	9,000	-		-	Stock Option (right to buy)
Geoffrey F. Cox	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	12,700	12,700	-		-	Stock Option (right to buy)
John P. Richard	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	12,700	12,700	-		-	Stock Option (right to buy)
John P. Richard	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	9,000	9,000	-		-	Stock Option (right to buy)
Richard J. Markham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	9,000	9,000	-		-	Stock Option (right to buy)
Richard J. Markham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	12,700	12,700	-		-	Stock Option (right to buy)
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	12,700	12,700	-		-	Stock Option (right to buy)
Michael J. Finney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	9,000	9,000	-		-	Stock Option (right to buy)
Margaret Echerd	VP, Corporate Controller, PAO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2019	70,444	70,444	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2019	124,061	124,061	-		-	Stock Option (right to buy)
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2019	363,261	363,261	-		-	Stock Option (right to buy)
Michael J. Finney	Director	Purchase of securities on an exchange or from another person at price $ 1.10 per share.	11 Apr 2019	181,818	452,572 (0%)	1%	1.1	200,000	Common Stock
Michael J. Finney	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Apr 2019	181,818	181,818	-		-	Common Stock Warrant
Sean N. Tucker	Chief Scientific Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Apr 2019	27,273	27,273	-		-	Common Stock Warrant (right to buy)
Sean N. Tucker	Chief Scientific Officer	Purchase of securities on an exchange or from another person at price $ 1.10 per share.	11 Apr 2019	27,273	52,661 (0%)	0%	1.1	30,000	Common stock
John Harland	Chief Financial Officer	Other type of transaction at price $ 0.00 per share.	11 Sep 2018	761	761 (0%)	0%		0	Common Stock
Michael J. Finney	None	Other type of transaction at price $ 0.00 per share.	11 Sep 2018	34,958	270,754 (3%)	0%		0	Common Stock
Michael J. Finney	None	Purchase of securities on an exchange or from another person at price $ 2.91 per share.	04 Jun 2018	65	232,043 (3%)	0%	2.9	189	Common Stock
Michael J. Finney	None	Purchase of securities on an exchange or from another person at price $ 2.91 per share.	04 Jun 2018	800	233,978 (3%)	0%	2.9	2,328	Common Stock
Michael J. Finney	None	Purchase of securities on an exchange or from another person at price $ 3.46 per share.	04 Jun 2018	2,000	231,978 (3%)	0%	3.5	6,920	Common Stock
Michael J. Finney	None	Purchase of securities on an exchange or from another person at price $ 4.27 per share.	04 Jun 2018	1,000	229,978 (3%)	0%	4.3	4,270	Common Stock
Michael J. Finney	None	Purchase of securities on an exchange or from another person at price $ 2.92 per share.	04 Jun 2018	1,135	233,178 (3%)	0%	2.9	3,314	Common Stock
John Harland	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2018	18,000	18,000	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2018	14,000	14,000	-		-	Stock Option (right to buy)
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2018	110,700	110,700	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Mar 2018	2,013	0	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.49 per share.	12 Mar 2018	2,013	47,653 (0%)	0%	6.5	13,064	Common Stock
Jan Leschly	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	30,793,670	30,793,670 (39%)	39%		0	Common Stock
Richard J. Markham	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	30,793,670	30,793,670 (39%)	39%		0	Common Stock
John Harland	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	4,087	4,087	-		-	Stock Option (right to buy)
John Harland	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	9,563	9,563	-		-	Stock Option (right to buy)
John Harland	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	8,255	8,255	-		-	Stock Option (right to buy)
John Harland	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	7,047	7,047	-		-	Stock Option (right to buy)
Michael J. Finney	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	1,818	230,796 (0%)	0%		0	Common Stock
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	2,014	2,014	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	4,027	4,027	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	9,060	9,060	-		-	Stock Optin (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	7,731	7,731	-		-	Stock Optin (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	10,067	10,067	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	11,604	11,604	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	10,523	10,523	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	3,020	3,020	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	1,006	1,006	-		-	Stock Option (right to buy)
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	45,640	45,640 (0%)	0%		0	Common Stock
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	9,060	9,060 (0%)	0%		0	Common Stock
Sean N. Tucker	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	25,388	25,388 (0%)	0%		0	Common Stock
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	18,120	18,120	-		-	Stock Option (right to buy)
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	14,908	14,908	-		-	Stock Option (right to buy)
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	13,256	13,256	-		-	Stock Option (right to buy)
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	9,442	9,442	-		-	Stock Option (right to buy)
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	6,536	6,536	-		-	Stock Option (right to buy)
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	10,731	10,731	-		-	Stock Option (right to buy)
Wouter W. Latour	Director, President and Chief Executive	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2018	23,651	23,651	-		-	Stock Option (right to buy)
Michael R. Dougherty	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2017	20,000	105,000	-		-	Stock Option (Right to Buy)
Geoffrey F. Cox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2017	20,000	103,332	-		-	Stock Option (Right to Buy)
Armando Anido	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2017	20,000	75,000	-		-	Stock Option (Right to Buy)
Anne M. Vanlent	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2017	20,000	105,000	-		-	Stock Option (Right to Buy)
Russell H. Plumb	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2017	20,000	622,453	-		-	Stock Option (Right to Buy)
John P Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2017	20,000	105,000	-		-	Stock Option (Right to Buy)
Michael W. Dunne	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2017	20,000	75,000	-		-	Stock Option (Right to Buy)
Mark P. Colonnese	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Apr 2017	400,000	775,000	-		-	Stock Option (Right to Buy)
Joseph M. Patti	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Apr 2017	650,000	2,113,304	-		-	Stock Option (Right to Buy)
Joseph M. Patti	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Aug 2016	380,000	1,478,929	-		-	Stock Option (Right to Buy)
Mark P. Colonnese	CFO and EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jul 2016	150,000	375,000	-		-	Stock Option (Right to Buy)
Michael R. Dougherty	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2016	20,000	20,000	-		-	Stock Option (Right to Buy)
Geoffrey F. Cox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2016	20,000	20,000	-		-	Stock Option (Right to Buy)
Armando Anido	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2016	20,000	20,000	-		-	Stock Option (Right to Buy)
Anne M. Vanlent	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2016	20,000	20,000	-		-	Stock Option (Right to Buy)
Russell H. Plumb	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2016	20,000	20,000	-		-	Stock Option (Right to Buy)
John P Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2016	20,000	20,000	-		-	Stock Option (Right to Buy)
Michael W. Dunne	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2016	20,000	20,000	-		-	Stock Option (Right to Buy)
Russell H. Plumb	Director, Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2016	9,167	9,167	-		-	Stock Option (Right to Buy)
Mark P. Colonnese	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	09 Feb 2016	6,700	7,000	-		-	Common Stock
Mark P. Colonnese	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	09 Feb 2016	300	300	-		-	Common Stock
Mark P. Colonnese	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2015	225,000	225,000	-		-	Stock Option (Right to Buy)
Joseph M. Patti	Director, CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	25 Sep 2015	2,500	126,128	-		-	Common stock
Joseph M. Patti	Director, CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	25 Sep 2015	2,500	123,628	-		-	Common stock
Armando Anido	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Sep 2015	35,000	35,000	-		-	Stock Option (Right to Buy)
Michael W. Dunne	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Sep 2015	35,000	35,000	-		-	Stock Option (Right to Buy)
Russell H. Plumb	Director, Executive Chairman	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	16 Sep 2015	12,140	203,213	-		-	Common Stock
Michael R. Dougherty	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Aug 2015	5,000	5,000	-		-	Stock Option (Right to Buy)
Geoffrey F. Cox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Aug 2015	5,000	5,000	-		-	Stock Option (Right to Buy)
Anne M. Vanlent	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Aug 2015	5,000	5,000	-		-	Stock Option (Right to Buy)
Joseph M. Patti	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Aug 2015	250,000	250,000	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Aug 2015	5,000	5,000	-		-	Stock Option (Right to Buy)
James Fox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Aug 2015	2,500	2,500	-		-	Restricted Stock Unit
Peter Azzarello	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Aug 2015	85,000	85,000	-		-	Stock Option (Right to Buy)
Anne M. Vanlent	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	22 Jun 2015	35,000	35,000	-		-	Common Stock
James Fox	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	09 Jun 2015	70,000	100,614	-		-	Common stock
Michael R. Dougherty	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2015	15,000	15,000	-		-	Stock Option (Right to Buy)
Geoffrey F. Cox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2015	15,000	15,000	-		-	Stock Option (Right to Buy)
Anne M. Vanlent	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2015	15,000	15,000	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2015	15,000	15,000	-		-	Stock Option (Right to Buy)
James Fox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2015	7,500	7,500	-		-	Restricted Stock Unit
Joseph M. Patti	Director, CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	27 Mar 2015	10,000	121,128	-		-	Common stock
Joseph M. Patti	Director, CEO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	27 Mar 2015	10,000	111,128	-		-	Common stock
Russell H. Plumb	Director, Vice Chairmen	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2014	40,000	40,000	-		-	Restricted Stock Unit
Joseph M. Patti	CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2014	475,000	475,000	-		-	Stock Option (right to buy)
Peter Azzarello	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2014	130,000	130,000	-		-	Stock Option (right to buy)
Joseph M. Patti	EVP, Corporate Dev & Strategy	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	30 Jun 2014	10,000	68,241	-		-	Common Stock
Joseph M. Patti	EVP, Corporate Dev & Strategy	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	27 Jun 2014	800	67,241	-		-	Common Stockli
Joseph M. Patti	EVP, Corporate Dev & Strategy	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	27 Jun 2014	4,200	66,441	-		-	Common Stock
Russell H. Plumb	Director, CEO & President	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Jun 2014	4,331	102,579	-		-	Common Stock
Russell H. Plumb	Director, CEO & President	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Jun 2014	2,700	98,248	-		-	Common Stock
Russell H. Plumb	Director, CEO & President	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Jun 2014	2,310	104,889	-		-	Common Stock
Russell H. Plumb	Director, CEO & President	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Jun 2014	22,690	127,579	-		-	Common Stock
Joseph M. Patti	EVP, Corporate Dev & Strategy	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Jun 2014	2,621	62,241	-		-	Common Stock
Joseph M. Patti	EVP, Corporate Dev & Strategy	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Jun 2014	2,995	59,620	-		-	Common Stock
Joseph M. Patti	EVP, Corporate Dev & Strategy	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Jun 2014	8,451	56,225	-		-	Common Stock
Joseph M. Patti	EVP, Corporate Dev & Strategy	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Jun 2014	400	56,625	-		-	Common Stock
Michael R. Dougherty	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2014	15,000	15,000	-		-	Stock Option (Right to Buy)
Geoffrey F. Cox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2014	15,000	15,000	-		-	Stock Option (Right to Buy)
Anne M. Vanlent	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2014	15,000	15,000	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2014	15,000	15,000	-		-	Stock Option (Right to Buy)
James Fox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2014	7,500	7,500	-		-	Restricted Stock Unit
Richard Hill	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2014	7,500	7,500	-		-	Restricted Stock Unit
Russell H. Plumb	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Dec 2013	25,000	25,000	-		-	Market Stock Units
Russell H. Plumb	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Dec 2013	100,000	100,000	-		-	Stock Option (Right to Buy)
Joseph M. Patti	EVP, Corporate Dev & Strategy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Dec 2013	62,500	62,500	-		-	Stock Option (Right to Buy)
Joseph M. Patti	EVP, Corporate Dev & Strategy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Dec 2013	15,625	15,625	-		-	Market Stock Units
Peter Azzarello	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Dec 2013	4,375	4,375	-		-	Market Stock Units
Peter Azzarello	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Dec 2013	17,500	17,500	-		-	Stock Option (Right to Buy)
John P. Richard	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Aug 2013	30,000	30,000	-		-	Stock Option (Right to Buy)
Michael R. Dougherty	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2013	30,000	30,000	-		-	Stock Option (Right to Buy)
Geoffrey F. Cox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2013	15,000	15,000	-		-	Stock Option (Right to Buy)
Peter Cook	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2013	8,700	100,127	-		-	Common Stock
Anne M. Vanlent	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2013	30,000	30,000	-		-	Stock Option (Right to Buy)
James Fox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2013	8,700	8,700	-		-	Common Stock
Jeffery Errington	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2013	15,000	15,000	-		-	Stock Option (Right to Buy)
Richard Hill	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2013	8,700	9,950	-		-	Common Stock
Russell H. Plumb	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Nov 2012	573,286	573,286	-		-	Stock Option (Right to Buy)
Russell H. Plumb	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Nov 2012	143,322	143,322	-		-	Common Stock
Joseph M. Patti	EVP, Corporate Dev & Strategy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Nov 2012	358,304	358,304	-		-	Stock Option (Right to Buy)
Joseph M. Patti	EVP, Corporate Dev & Strategy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Nov 2012	71,661	71,661	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Apr 2012	5,167	105,128	-		-	Common Stock
Geoffrey F. Cox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2011	40,000	40,000	-		-	Stock Option (right to buy)
Timothy P. Lynch	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2011	20,000	20,000	-		-	Stock Option (right to buy)
David L. Castaldi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2011	20,000	20,000	-		-	Stock Option (right to buy)
Richard A. Harvey	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2011	20,000	20,000	-		-	Stock Option (right to buy)
Peter B. Davis	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2011	20,000	20,000	-		-	Stock Option (right to buy)
Jason M. Aryeh	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2011	20,000	20,000	-		-	Stock Option (right to buy)
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 May 2011	7,500	115,171	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 May 2011	4,876	110,295	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Other type of transaction at price $ 0.00 per share.	01 Apr 2011	3,096	333,733	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Other type of transaction at price $ 0.00 per share.	01 Apr 2011	3,023	336,756	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2011	50,000	386,756	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Apr 2011	13,283	373,473	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2011	150,000	150,000	-		-	Stock Option (right to buy)
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2011	90,000	90,000	-		-	Stock Option (right to buy)
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2011	36,000	131,267	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Apr 2011	8,596	122,671	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2011	75,000	75,000	-		-	Stock Option (right to buy)
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Apr 2011	6,300	41,050	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2011	30,000	71,050	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	15 Mar 2011	4,900	131,783	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	14 Mar 2011	2,400	137,683	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	14 Mar 2011	1,000	136,683	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Mar 2011	9,900	144,983	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Mar 2011	4,900	140,083	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Mar 2011	9,900	154,883	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Jan 2011	3,181	330,637	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Jan 2011	2,985	95,267	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 Dec 2010	15,093	0	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	15 Dec 2010	1,907	15,093	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	08 Dec 2010	4,705	181,783	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Dec 2010	6,700	186,488	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Nov 2010	4,900	196,483	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Nov 2010	463	196,020	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Nov 2010	2,832	193,188	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Nov 2010	4,900	201,383	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	09 Nov 2010	6,400	217,483	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	09 Nov 2010	11,200	206,283	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Oct 2010	12,020	232,436	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Oct 2010	8,553	223,883	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Oct 2010	4,422	244,456	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Aug 2010	600	248,878	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	26 Jul 2010	1,500	44,225	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Jul 2010	1,625	45,725	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Jun 2010	2,147	249,478	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Jun 2010	258	251,625	-		-	Common Stock
Geoffrey F. Cox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2010	40,000	40,000	-		-	Stock Option (right to buy)
Geoffrey F. Cox	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	20 May 2010	1,908	25,679	-		-	Common Stock
Timothy P. Lynch	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2010	20,000	20,000	-		-	Stock Option (right to buy)
David L. Castaldi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2010	20,000	20,000	-		-	Stock Option (right to buy)
Richard A. Harvey	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2010	20,000	20,000	-		-	Stock Option (right to buy)
Peter B. Davis	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2010	20,000	20,000	-		-	Stock Option (right to buy)
Peter B. Davis	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	20 May 2010	3,816	14,630	-		-	Common Stock
Jason M. Aryeh	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2010	20,000	20,000	-		-	Stock Option (right to buy)
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	300	112,952	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	50	112,902	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	850	112,052	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	1,000	111,052	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	3,205	107,847	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	700	107,147	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	3,592	103,555	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	100	103,455	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	1,900	101,555	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	100	101,455	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	1,400	100,055	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	1,003	99,052	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	600	98,452	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 May 2010	200	98,252	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 Apr 2010	2,250	47,350	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Apr 2010	200	114,952	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Apr 2010	500	114,452	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Apr 2010	600	113,852	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Apr 2010	600	113,252	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Apr 2010	200	118,300	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Apr 2010	928	117,372	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Apr 2010	1,520	115,852	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Apr 2010	700	115,152	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2010	125,000	125,000	-		-	Stock Option (Right to Buy)
Raafat E.F. Fahim	Director, President, CEO and CFO	Other type of transaction at price $ 0.00 per share.	01 Apr 2010	5,404	278,414	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Other type of transaction at price $ 0.00 per share.	01 Apr 2010	5,404	283,818	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2010	50,000	333,818	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2010	90,000	90,000	-		-	Stock Option (Right to Buy)
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2010	36,000	118,500	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2010	24,000	53,650	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Apr 2010	250	53,400	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Apr 2010	400	53,000	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Apr 2010	1,300	51,700	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops		01 Apr 2010	2,100	49,600	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2010	60,000	60,000	-		-	Stock Option (Right to Buy)
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Mar 2010	64,793	252,117	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Mar 2010	234	251,883	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	22 Mar 2010	28,510	316,910	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Mar 2010	7,800	345,420	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Mar 2010	6,381	352,820	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 Mar 2010	200	352,620	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Mar 2010	8,800	361,820	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Mar 2010	2,619	359,201	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Mar 2010	9,873	29,650	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	15 Mar 2010	200	370,620	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2010	1,000	1,000	-		-	Stock Option (right to buy)
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Mar 2010	180,700	387,420	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Mar 2010	1,125	14,625	-		-	Stock Option (Right to Buy)
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Mar 2010	1,125	40,648	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	11 Mar 2010	1,125	39,523	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	10 Mar 2010	16,100	568,120	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	08 Mar 2010	3,200	584,220	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Mar 2010	2,250	15,750	-		-	Stock Option (Right to Buy)
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Other type of transaction at price $ 0.00 per share.	02 Mar 2010	5,404	39,523	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Mar 2010	2,250	41,773	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	02 Mar 2010	2,250	39,523	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 Jan 2010	13,800	587,420	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	12 Jan 2010	86,200	601,220	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	06 Jan 2010	42,365	737,020	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	06 Jan 2010	3,443	733,577	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	06 Jan 2010	46,157	687,420	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	22 Dec 2009	8,035	779,385	-		-	Common stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Dec 2009	4,045	787,420	-		-	Common Stock
Peter B. Davis	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Nov 2009	800	8,614	-		-	Common stock
Peter B. Davis	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Nov 2009	2,200	10,814	-		-	Common stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Nov 2009	602	82,500	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Nov 2009	2,000	95,740	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Nov 2009	7,136	88,604	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Nov 2009	5,502	83,102	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Nov 2009	2,500	98,740	-		-	Common Stock
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Sale of securities on an exchange or to another person at price $ 0.00 per share.	19 Nov 2009	1,000	97,740	-		-	Common Stock
Timothy P. Lynch	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	3,846	0	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	500	917,965	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	500	917,465	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	5,000	912,465	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	300	912,165	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	100	912,065	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	6,232	905,833	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	1,909	903,924	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	10,058	893,866	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	2,100	891,766	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	10,335	881,431	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	33,803	847,628	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	43,163	804,465	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	1,000	803,465	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	1,000	802,465	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	500	801,965	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	500	801,465	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	5,000	796,465	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	200	977,174	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	58,709	918,465	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	4,804	791,661	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	17 Nov 2009	196	791,465	-		-	Common Stock
Jason M. Aryeh	None		16 Nov 2009	17,000	1,232,650	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	2,884	1,229,766	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	300	1,229,466	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	1,300	1,228,166	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	2,500	1,225,666	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	3,375	1,222,291	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	2,500	1,219,791	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	11,525	1,208,266	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	1,700	1,206,566	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	2,700	1,203,866	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	1,200	1,202,666	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	400	1,202,266	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	4,339	1,197,927	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	9,175	1,188,752	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	38,319	1,150,433	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	102,912	1,047,521	-		-	Common Stock
Jason M. Aryeh	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	70,147	977,374	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	7,674	38,018	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	2,000	36,018	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Sale of securities on an exchange or to another person at price $ 0.00 per share.	16 Nov 2009	4,900	31,118	-		-	Common Stock
David M. Knott	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Jun 2009	55,500	1,140,000	-		-	Common Stock
David M. Knott	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Jun 2009	53,800	1,784,153	-		-	Common Stock
David M. Knott	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Jun 2009	300	70,100	-		-	Common Stock
David M. Knott	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Jun 2009	45,600	1,094,400	-		-	Common Stock
David M. Knott	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Jun 2009	44,200	1,739,953	-		-	Common Stock
David M. Knott	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	29 Jun 2009	200	69,900	-		-	Common Stock
Stephen G. Sudovar	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2009	20,000	20,000	-		-	Stock Option (right to buy)
Geoffrey F. Cox	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2009	40,000	40,000	-		-	Stock Option (right to buy)
Timothy P. Lynch	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2009	20,000	20,000	-		-	Stock Option (right to buy)
David L. Castaldi	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2009	20,000	20,000	-		-	Stock Option (right to buy)
Linda Jenckes	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2009	20,000	20,000	-		-	Stock Option (right to buy)
Richard A. Harvey	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2009	20,000	20,000	-		-	Stock Option (right to buy)
Peter B. Davis	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2009	20,000	20,000	-		-	Stock Option (right to buy)
Jason M. Aryeh	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2009	20,000	20,000	-		-	Stock Option (right to buy)
Raafat E.F. Fahim	Director, President, CEO and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2009	45,000	270,063	-		-	Common Stock
Raafat E.F. Fahim	Director, President, CEO and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2009	115,000	115,000	-		-	Stock Option (Right to Buy)
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2009	90,000	90,000	-		-	Stock Option (Right to Buy)
Paul Kessler	SVP Clinical, Med. & Reg.; CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2009	30,000	101,240	-		-	Common Stock
Matthew W. Kalnik	SVP Strategic Plan. & Bus. Ops	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2009	18,000	45,692	-		-	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low in past week

Insider Trading disclosures for Vaxart Inc

The latest disclosure was made by Sean N. Tucker in Vaxart Inc where a trade of 9,242 Common Stock done at an average price of $0.7 was reported to US exchanges on Feb. 2, 2025.

Screeners based on Insider Trading and SAST parameters